What changed in Edwards Lifesciences Corporation's latest annual report
In the year ended 31 Dec 2025, Edwards Lifesciences Corporation's revenue rose 11.5% to USD 6.07bn, from USD 5.44bn; net income fell 74.3% to USD 1.07bn, from USD 4.17bn; total liabilities rose 12.3% to USD 3.36bn, from USD 2.99bn.
Year ended 31 Dec 2025. Source: 10-K filed 25 Feb 2026, read it on SEC EDGAR.
USD 5.44bn to USD 6.07bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 5.44bn | 6.07bn | Up 11.5% |
| Net income | 4.17bn | 1.07bn | Down 74.3% |
| Total assets | 13.06bn | 13.70bn | Up 4.9% |
| Total liabilities | 2.99bn | 3.36bn | Up 12.3% |
| Long-term debt | 597.70m | 598.30m | Up 0.1% |
| Cash and cash equivalents | 3.05bn | 2.94bn | Down 3.5% |
| Shareholders' equity | 10.00bn | 10.34bn | Up 3.4% |
Questions people ask
Did Edwards Lifesciences Corporation's revenue grow last year?
Revenue grew 11.5%, from USD 5.44bn to USD 6.07bn in the year ended 31 Dec 2025.
Is Edwards Lifesciences Corporation profitable?
Yes. Net income was USD 1.07bn in the year ended 31 Dec 2025. The year before: USD 4.17bn.
How much cash and debt does Edwards Lifesciences Corporation have?
At its latest year end (31 Dec 2025), Edwards Lifesciences Corporation reported cash and cash equivalents of USD 2.94bn and long-term debt of USD 598.30m.
Where do these numbers come from?
From Edwards Lifesciences Corporation's own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Edwards Lifesciences Corporation?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical, Inc.Cash and cash equivalents up 66.1%
- STERIS plcNet income up 27.3%
- Zimmer Biomet Holdings, Inc.Long-term debt up 29.8%
- Align Technology, Inc.Total liabilities down 7.5%